Patents by Inventor Rodney Pearlman

Rodney Pearlman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180098934
    Abstract: Described herein are systems and methods for transmucosal delivery of active agents. In some embodiments, a system may comprise one or more mucoadhesive devices configured for release of an active agent.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 12, 2018
    Inventors: Baruch Z. HARRIS, Vijay M. K. MURTHY, David Adam STEINBERG, Rodney PEARLMAN, Howard Brian ROSEN, Robert Samuel LANGER, Hila ESPTEIN-BARASH, Jonathan Robert BEHR, Samir Suresh MITRAGOTRI
  • Publication number: 20170196800
    Abstract: Described herein are systems and methods for transmucosal delivery of active agents. In some embodiments, a system may comprise one or more mucoadhesive devices configured for release of an active agent.
    Type: Application
    Filed: November 18, 2016
    Publication date: July 13, 2017
    Inventors: Baruch Z. HARRIS, Vijay M. K. MURTHY, David Adam STEINBERG, Rodney PEARLMAN, Howard Brian ROSEN, Robert Samuel LANGER, Hila ESPTEIN-BARASH, Jonathan Robert BEHR, Samir Suresh MITRAGOTRI
  • Publication number: 20160101056
    Abstract: Described herein are systems and methods for transmucosal delivery of active agents. In some embodiments, a system may comprise one or more mucoadhesive devices configured for release of an active agent.
    Type: Application
    Filed: September 28, 2015
    Publication date: April 14, 2016
    Inventors: Baruch Z. HARRIS, Vijay M. K. MURTHY, David Adam STEINBERG, Rodney PEARLMAN, Howard Brian ROSEN, Robert Samuel LANGER, Hila ESPTEIN-BARASH, Jonathan Robert BEHR, Samir Suresh MITRAGOTRI
  • Publication number: 20150174076
    Abstract: Described herein are systems and methods for transmucosal delivery of active agents. In some embodiments, a system may comprise one or more mucoadhesive devices configured for release of an active agent.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 25, 2015
    Inventors: Baruch Z. Harris, Vijay M.K. Murthy, David Adam Steinberg, Rodney Pearlman, Howard Brian Rosen, Robert Samuel Langer, Hila Esptein-Barash, Jonathan Robert Behr, Samir Suresh Mitragotri
  • Publication number: 20100158905
    Abstract: Combination therapy is disclosed herein for the treatment an arthritic condition (e.g. rheumatoid arthritis, osteoarthritis or psoriatic arthritis). The therapies disclosed herein comprise administering tranilast or an analogous compound in combination with a pharmaceutical agent, such as a non-steroidal anti-inflammatory drug, a disease-modifying drug, a COX-2 inhibitor, an antibiotic, an analgesic or combination thereof.
    Type: Application
    Filed: December 19, 2009
    Publication date: June 24, 2010
    Applicant: NUON THERAPEUTICS, INC.
    Inventors: Rodney PEARLMAN, Helen JENKINS, Tito SERAFINI
  • Publication number: 20100160351
    Abstract: Disclosed is a pharmaceutical composition comprising (a) a first therapeutic agent, wherein the first therapeutic agent is a compound of formula II: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, X and n are as defined herein; (b) a second therapeutic agent, wherein the second therapeutic agent is a uric acid synthesis inhibitor or a uricosuric agent; and (c) a pharmaceutically acceptable diluent or carrier.
    Type: Application
    Filed: December 19, 2009
    Publication date: June 24, 2010
    Applicant: NUON THERAPEUTICS, INC.
    Inventors: Helen JENKINS, Michael KITT, Rodney PEARLMAN, Tito SERAFINI, Eugene THORSETT
  • Publication number: 20050233976
    Abstract: The invention provides methods for treating a symptom of MCI as well as methods for slowing the progression from MCI to AD.
    Type: Application
    Filed: May 29, 2003
    Publication date: October 20, 2005
    Applicant: SAEGIA PHARMACEUTICALS, INC.
    Inventor: Rodney Pearlman
  • Publication number: 20050222093
    Abstract: The invention provides methods for treating cognitive decline that is associated with systemic stress.
    Type: Application
    Filed: May 23, 2005
    Publication date: October 6, 2005
    Inventors: Rodney Pearlman, Ken Tempero
  • Publication number: 20050187196
    Abstract: The invention provides methods and medicaments for improving attentiveness in humans, including subjects diagnosed with attention disorders. In one aspect, a GABAB receptor antagonist, such as 3-aminopropyl-(n-butyl)-phosphinic acid (ABPA), is used to improve attention.
    Type: Application
    Filed: February 23, 2005
    Publication date: August 25, 2005
    Applicant: Saegis Pharmaceuticals, Inc.
    Inventors: Annette Madrid, Helen Jenkins, Rodney Pearlman
  • Publication number: 20020187977
    Abstract: The invention provides methods for treating cognitive decline that is associated with systemic stress.
    Type: Application
    Filed: March 15, 2002
    Publication date: December 12, 2002
    Inventors: Rodney Pearlman, Ken Tempero
  • Patent number: 5096885
    Abstract: A stable pharmaceutically acceptable formulation containing human growth hormone, glycine, mannitol, a buffer, and optionally, a non-ionic surfactant is disclosed. The formulation contains human growth-hormone: glycine in 1:50-200 molar ratios. Also disclosed are associated means and methods for preparing and using such formulations.
    Type: Grant
    Filed: April 15, 1988
    Date of Patent: March 17, 1992
    Assignee: Genentech, Inc.
    Inventors: Rodney Pearlman, James Q. Oeswein